EGFR and gastric cancer: Berberine synergized with icotinib to decrease EGFR expression and activity, induce autophagy and apoptosis, and reduce metastasis in xenograft models (147). Similarly, berberine inhibited EGFR-induced STAT3 activity to increase gastric cancer sensitivity to the EGFR inhibitors cetuximab and erlotinib (148).